Objective:To observe the clinical efficacy of Jinkui Shenqi Pill in the treatment of diabetic nephropathy of stage Ⅱ-Ⅲ.Methods:Seventy-four cases were divided into the control group and the study group according to the random number table method,37 cases in each group.Both groups were treated with dapagliflozin and benazepril and the study group were additionally treated with Jingui Shenqi Pills.Results:The total effective rate and estimated glomerular filtration rate(eGFR)in the study group were higher than those in the control group(P＜0.05).The scores of TCM syndromes,serum creatinine(SCR),blood urea nitrogen(BUN),24-hour urinary total protein(TUP),urinary microalbumin/urinary creatinine(UMA/UCR)and fasting blood glucose(FBG)were lower than those in the control group(P＜0.05).Conclusion:Jingui Shenqi Pill could improve the curative effect in the treatment of diabetic nephropathy of stage Ⅱ-Ⅲ.
Diabetic nephropathy of Ⅱ-Ⅲ stageJingui Shenqi PillDapagliflozinBenazepril
万方数据
维普
